Theme 2017-08-29T12:33:22+00:00

Abstract thematic and track guidance

Abstract thematic and track guidance
The conference will focus on leadership and innovation in harm reduction in the Eastern Africa region, and the current policy situation and what needs to change. Presentations are welcome from researchers, advocates, policy makers, People Who Use Drugs (PWUD) and program implementers. Key areas of focus will be leadership, health, law and the community. The following Tracks should be considered:

  • Epidemiology and Prevention science
  • Community Systems Strengthening
  • Law, Human rights, Social science and political science
  • Health systems Economics and implementation science
  • Clinical Science, treatment and care
  • Global perspectives and implementation of harm reduction

Track A: Epidemiology and Prevention Science: This track covers prevention research and issues related to the design, implementation and evaluation of prevention programs on HIV and harm reduction to reach the SDGs. It will include examination of Research, methodological and programmatic advances in the continuum of prevention, particularly best practices in HIV prevention for people who use and inject drugs in resource-limited settings. Strategies to put HIV prevention research into practice, efforts to promote preparedness for bio-medical prevention technologies, and research on new prevention approaches including microbicides, vaccines and pre- and post-exposure prophylaxis are also encouraged. This Track will also address co-morbidities (Hepatitis, Tuberculosis, and STI’s, communicable end emerging diseases).

  • Global trends and emerging information on harm reduction
  • Emerging harm reduction programs in Eastern Africa
  • Universal access to health: addressing the health needs of people who use drugs in the region
  • Responses for women, adolescents and young people using drugs in the region
  • Responses for people with disabilities using drugs
  • Emerging research among PWUD; including recent size estimates

Track B: Community Systems Strengthening: This track will cover meaningful inclusion of communities in responding to drug use in the region. Invitations are open for abstracts that focus on community mobilization, community-driven responses and community advocacy

  • Organizing communities of drug users for effective advocacy
  • Best practices in creating space for communities to engage stakeholders
  • Community mobilization and engagement

Track C: Law, Human rights, Social science and political science: This track aims to highlight new knowledge and address gaps in the conversion of behavioural and social science evidence into practice, and to contribute to the building of theory and understanding in harm reduction social science. The track also aims to promote understanding of the individual, social and structural determinants of HIV-related risk, vulnerability and impact, to inform development of effective and sustainable HIV responses that are based on human dignity and individual entitlements.

  • Grounding harm reduction in regional and national policy
  • Existing policies and implications on harm reduction
  • Policies under review and progress covered
  • Stigma, Discrimination and the Legal Environment
  • Sex, Sexuality, gender relationship and HIV
  • Social theories and knowledge production
  • Socio-cultural determinants of health among PWID
  • Structural determinants of health among PWID

Track D: Health systems Economics and implementation science: This track will aim to provide new insights into the status of the health systems and its capacity and challenges to expanding treatment and prevention in resource-limited settings. At the same time, issues related to health economics, integration of health programs, country ownership of national health and HIV programs, and advancement of a comprehensive and integrated approach to health and rights will be discussed.

  • Global, Regional and national commitments for domestic resource mobilization in harm reduction
  • Funding for harm Reduction programs in Eastern Africa region
  • Cost effectiveness of ham reduction programs
  • Best practices in implementing harm reduction

Track E: Clinical Science, Treatment and Care: Focus will be on clinical aspects of HIV care and treatment. This will encompass issues of co infection and co morbidities as well as treatment initiation, adherence and retention. Main focus will be the intersection of drug use and HIV treatment and care.

  • Diagnosis and management of co-infections/co-morbidities
  • Antiretroviral therapy
  • Adherence, retention and fall out from treatment
  • ART in children and pregnant women

Track F: Global Perspectives and Implementation of Harm Reduction: This track will focus on evidence of implementing harm reduction interventions from other settings in Africa and internationally. The themes in track A to E can guide development of abstracts under this theme.

  • National and regional harm reduction programs in other settings outside Eastern Africa